Table 1.

Clinical characteristics of patients who underwent radical cystectomy for bladder cancer in the VHA from 2004 through 2018 stratified by baseline kidney function.

Baseline eGFR	eGFR <60	eGFR ≥60	Missing
No. of patients	1081	2121	158
Age at surgery (yr), n (%)	70.6 ± 7.9	65.9 ± 7.7	67.1 ± 8.7
≤59	91 (8.4)	429 (20.2)	33 (20.9)
60–69	433 (40.1)	1,101 (51.9)	69 (43.7)
70–79	418 (38.7)	503 (23.7)	41 (25.9)
≥80	139 (12.9)	88 (4.1)	15 (9.5)
Sex, n (%)
Female	7 (0.6)	21 (1.0)	3 (1.9)
Male	1074 (99.4)	2100 (99.0)	155 (98.1)
Race, n (%)
White	937 (86.7)	1815 (85.6)	121 (76.6)
Black	91 (8.4)	213 (10.0)	25 (15.8)
Other/unknown	37 (3.4)	49 (2.3)	9 (5.7)
Missing	16 (1.5)	44 (2.1)	3 (1.9)
Pathologic T stage, n (%)
T0	22 (2.0)	91 (4.3)	3 (1.9)
T1	94 (8.7)	247 (11.6)	23 (14.6)
T2	207 (19.1)	510 (24.0)	26 (16.5)
T3	273 (25.3)	427 (20.1)	34 (21.5)
T4	161 (14.9)	178 (8.4)	25 (15.8)
TA	22 (2.0)	37 (1.7)	3 (1.9)
CIS	23 (2.1)	65 (3.1)	4 (2.5)
Unknown	229 (21.2)	464 (21.9)	34 (21.5)
Missing	50 (4.6)	102 (4.8)	6 (3.8)
Pathologic N stage, n (%)
N0	547 (50.6)	1184 (55.8)	78 (49.4)
N1	70 (6.5)	128 (6.0)	13 (8.2)
N2	127 (11.7)	181 (8.5)	19 (12.0)
N3	14 (1.3)	27 (1.3)	4 (2.5)
Unknown	273 (25.3)	501 (23.6)	38 (24.1)
Missing	50 (4.6)	100 (4.7)	6 (3.8)
Pathologic M stage, n (%)
M0	368 (34.0)	677 (31.9)	61 (38.6)
M1	18 (1.7)	17 (0.8)	7 (4.4)
Unknown	188 (17.4)	315 (14.9)	39 (24.7)
Missing	507 (46.9)	1112 (52.4)	51 (32.3)
Charlson Comorbidity Index, n (%)	6.3 ± 2.7	4.9 ± 2.5	5.2 ± 2.6
2	72 (6.7)	408 (19.2)	27 (17.1)
3	80 (7.4)	369 (17.4)	24 (15.2)
4	158 (14.6)	337 (15.9)	25 (15.8)
5	173 (16.0)	218 (10.3)	22 (13.9)
6+	598 (55.3)	789 (37.2)	60 (38.0)

CIS = carcinoma in situ; eGFR = estimated glomerular filtration rate; VHA = Veterans Health Administration.